Journal of Allergy and Clinical Immunology: In Practice
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma
2021
-
Prenatal egg consumption and infant sensitization and allergy to egg, peanut, and cow's milk in the CHILD Cohort
2021
-
Patient reported outcomes on food immunotherapy differ between countries and foods: results from COFAITH..
S2213-2198(25)00418-0.
2025
-
Mucus Plugging as a Prognostic Indicator for Biologic Treatment Response in Severe Asthma..
13:1123-1124.
2025
-
Patient-facing digital inhalers for asthma: a systematic review and meta-analysis.
S2213-2198(25)00408-8.
2025
-
Insect Allergy: Barriers in Training and Practice-A Work Group Report of the AAAAI Anaphylaxis Committee..
13:501-510.
2025
-
The Clinical Approach to Chronic Cough..
13:454-466.
2025
-
Improving Adherence Through Collaboration and Care Coordination in the Management of Food Allergies and Asthma..
12:3208-3215.
2024
-
Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis..
12:3404-3418.
2024
-
Atopic Dermatitis (Eczema) Guidelines 2023: Highlights..
12:2955-2965.
2024
-
Patient-Reported Outcome Measures in Chronic Spontaneous Urticaria, Angioedema, and Atopic Dermatitis..
12:2583-2590.
2024
-
A Media Advocacy Toolkit for the Allergist-Immunologist.
12:2678-2686.
2024
-
Age-Related Food Aversion and Anxiety Represent Primary Patient Barriers to Food Oral Immunotherapy.
12:1809-1818.e3.
2024
-
Concepts for the development of person-centred, digitally-enabled, Artificial Intelligence-assisted ARIA care pathways (ARIA 2024).
12:2648-2668.e2.
2024
-
Efficacy and Safety of Systemic Corticosteroids for Urticaria: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
12:1879-1889.e8.
2024
-
How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence.
12:1695-1704.
2024
-
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema.
12:1614-1621.
2024
-
Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update.
12:2325-2336.
2024
-
Decisions With Patients, Not for Patients: Shared Decision-Making in Allergy and Immunology.
12:2625-2633.
2024
-
Lime-Induced Phytophotodermatitis: A Rash That Requires Explicit Questioning..
12:1631-1632.
2024
-
The Safety and Efficacy of Baked Egg and Milk Dietary Advancement Therapy: A Systematic Review and Meta-Analysis.
12:2468-2480.
2024
-
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada.
12:2439-2444.e4.
2024
-
Flex-IT! Applying “Platform Trials” Methodology to Immunotherapy for Food Allergy in Research and Clinical Practice.
12:554-561.
2024
-
The Social and Home Environment: Impacts of Determinants of Health on Atopic Dermatitis, Pathways Toward Solutions, and Unique Considerations for Rural and Remote North American Indigenous Populations.
12:290-299.
2024
-
COVID-19 Treatments: Then and Now.
11:3321-3333.
2023
-
Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN.
11:3161-3168.e2.
2023
-
When Supplemental Formula Is Essential: Overcoming Barriers to Hypoallergenic Formula Access for Patients With Food Allergies.
11:2686-2692.
2023
-
Pediatric wheat-induced anaphylaxis from the Cross-Canada Anaphylaxis Registry: Clinical characteristics and management.
11:2592-2594.e1.
2023
-
Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis.
11:2043-2048.
2023
-
Evening ingestion as a potential reaction cofactor during peanut oral immunotherapy in children.
11:1964-1966.e2.
2023
-
Reply to “Don’t put all your eggs (and milk) in one basket”.
11:1982-1983.
2023
-
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction.
11:1385-1390.
2023
-
Are There Hidden Dangers Associated With Milk and Egg Dietary Advancement Therapy?.
11:1056-1062.
2023
-
Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States.
11:1100-1115.
2023
-
Reply to “Be smart in choosing antihistamines”.
11:1332-1333.
2023
-
Varying Approaches to Management of IgE-Mediated Food Allergy in Children Around the World.
11:1010-1027.e6.
2023
-
Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes.
11:1036-1046.
2023
-
A case series of dual biologics therapy for severe asthma.
11:335-340.e2.
2023
-
Boxed Warnings and Off-Label Use of Allergy Medications: Risks, Benefits, and Shared Decision Making.
10:3057-3063.
2022
-
Diphenhydramine: Time to Move on?.
10:3124-3130.
2022
-
Educational resources received by families after successful baked egg/baked milk oral food challenge: An international survey.
10:3328-3332.e2.
2022
-
Impact of Reaction Setting on the Management, Severity, and Outcome of Pediatric Food-Induced Anaphylaxis: A Cross-Sectional Study.
10:3163-3171.
2022
-
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study.
10:3008-3017.e4.
2022
-
Trustworthy Patient-Centered Guidelines: Insights From Atopic Dermatitis and a Proposal for the Future.
10:2875-2877.
2022
-
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis.
10:2657-2666.e8.
2022
-
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
10:2695-2709.
2022
-
Peanut Oral Immunotherapy With or Without H1 and H2 Antihistamine Premedication for Peanut Allergy (PISCES): A Placebo-Controlled Randomized Clinical Trial.
10:2386-2394.
2022
-
Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose.
10:1462-1467.
2022
-
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air.
10:343-345.e2.
2022
-
International Peanut Allergy Prevention, 6 Years After the Learning Early About Peanut Study.
10:71-77.
2022
-
Translating Evidence to Optimize Patient Care Using GRADE.
9:4221-4230.
2021
-
Antibody Deficiency, Chronic Lung Disease, and Comorbid Conditions: A Case-Based Approach.
9:3899-3908.
2021
-
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process.
9:3997-4004.
2021
-
Reply to “As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function”.
9:4179-4180.
2021
-
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
9:3546-3567.
2021
-
Management of Eosinophilic Esophagitis During Oral Immunotherapy.
9:3282-3287.
2021
-
Web-based Infant Food Introduction (WIFI): Feasibility and satisfaction of virtual allergist-supervised food introduction.
9:3521-3523.e1.
2021
-
The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.
9:2556-2561.
2021
-
The hidden allergen: Triton X-100, a derivative of polyethylene glycol.
9:2941-2941.
2021
-
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis.
9:2321-2333.
2021
-
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both.
9:2151-2157.
2021
-
Peanut allergen reaction thresholds during controlled food challenges in 2 Canadian randomized studies (Canada-ARM1 and PISCES).
9:2524-2526.e2.
2021
-
Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”.
9:2537-2539.
2021
-
A High Proportion of Canadian Allergists Offer Oral Immunotherapy but Barriers Remain.
9:1902-1908.
2021
-
An Approach to the Office-Based Practice of Food Oral Immunotherapy.
9:1826-1838.e8.
2021
-
Prenatal egg consumption and infant sensitization and allergy to egg, peanut, and cow's milk in the CHILD Cohort.
9:2109-2112.e2.
2021
-
Treatment Effect of the Tree Pollen SLIT-Tablet on Allergic Rhinoconjunctivitis During Oak Pollen Season.
9:1871-1878.
2021
-
A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough.
9:1640-1647.
2021
-
Sesame allergy a time burden for families of children with multiple food allergies.
9:1753-1755.e1.
2021
-
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World.
9:1438-1441.
2021
-
Fruit-Induced Anaphylaxis: Clinical Presentation and Management.
9:2825-2830.e2.
2021
-
Practical Challenges and Considerations for Early Introduction of Potential Food Allergens for Prevention of Food Allergy.
9:44-56.e1.
2021
-
The Sesame-Peanut Conundrum in Israel: Reevaluation of Food Allergy Prevalence in Young Children.
9:200-205.
2021
-
Weighing peanut candies used for oral immunotherapy mitigates variable peanut protein dose.
9:521-523.e1.
2021
-
Increasing Awareness of the Low Risk of Severe Reaction at Infant Peanut Introduction: Implications During COVID-19 and Beyond.
8:3259-3260.
2020
-
Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report.
8:2920-2936.e1.
2020
-
Managing Food Allergy in Schools During the COVID-19 Pandemic.
8:2845-2850.
2020
-
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change.
8:2851-2857.
2020
-
Anaphylaxis as a presenting symptom of food allergy in children with no known food allergy.
8:2811-2813.e2.
2020
-
Appointment characteristics during COVID-19 restrictions: A Canadian allergy/immunology centre perspective.
8:2837-2838.
2020
-
Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review.
8:2556-2564.e8.
2020
-
Virtually supported home peanut introduction during COVID-19 for at-risk infants.
8:2780-2783.
2020
-
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services.
8:2125-2134.
2020
-
Comparing food allergy prevalence in vulnerable and nonvulnerable Canadians.
8:2425-2430.e11.
2020
-
Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”.
8:2450-2452.
2020
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.
8:1477-1488.e5.
2020
-
Temporal trends in prevalence of food allergy in Canada.
8:1428-1430.e5.
2020
-
Using skin prick test to sesame paste in the diagnosis of sesame seed allergy.
8:1456-1458.
2020
-
When and how pediatric anaphylaxis cases reach the emergency department: Findings from the Cross-Canada Anaphylaxis Registry.
8:1406-1409.e2.
2020
-
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema.
8:901-911.
2020
-
Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma.
8:555-564.
2020
-
Eosinophilic Asthma.
8:465-473.
2020
-
Development of the Hereditary Angioedema Rapid Triage Tool.
8:310-317.e3.
2020
-
Timing of Introduction, Sensitization, and Allergy to Highly Allergenic Foods at Age 3 Years in a General-Population Canadian Cohort.
8:166-175.e10.
2020
-
Cough rhythms in asthma: Potential implication for management.
7:2024-2027.
2019
-
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
7:1793-1802.e2.
2019
-
Tissue compression and epinephrine deposition.
7:2096-2097.
2019
-
Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study.
7:1610-1618.e4.
2019
-
To stock or not to stock? Implementation of epinephrine autoinjectors in food establishments.
7:678-680.e5.
2019
-
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma.
6:1989-1998.e3.
2018
-
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
6:1733-1741.e3.
2018
-
Errors in the Use of Inhalers by Health Care Professionals: A Systematic Review.
6:987-995.
2018
-
Chronic Eosinophilic Pneumonia: A Diagnostic Challenge.
5:1737-1738.
2017
-
A Randomized Pragmatic Trial of Changing to and Stepping Down Fluticasone/Formoterol in Asthma.
5:1378-1387.e5.
2017
-
Epinephrine Autoinjectors: New Data, New Problems.
5:1180-1191.
2017
-
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.
5:1040-1049.e4.
2017
-
Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance.
5:649-659.e2.
2017
-
Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.
5:S1-S14.
2017
-
Food Allergen Labeling and Purchasing Habits in the United States and Canada.
5:345-351.e2.
2017
-
Primary Immune Deficiencies in the Adult: A Previously Underrecognized Common Condition.
4:1101-1107.
2016
-
Adjusting for nonresponse bias corrects overestimates of food allergy prevalence.
3:291-293.e2.
2015
-
Prevalence and Predictors of Food Allergy in Canada: A Focus on Vulnerable Populations.
3:42-49.
2015
-
Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial.
2:553-561.
2014
-
Use of abatacept in eosinophilic asthma.
2:220-221.
2014
-
Pollen Count and Presentation of Angiotensin-Converting Enzyme Inhibitor–Associated Angioedema.
1:468-473.e4.
2013
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)